These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6765359)

  • 1. [Influence of culture conditions (oxygenation) on the residual virulence of Brazil-BCG and Glaxo-BCG vaccines in mice].
    Feitosa JG; Gontijo Filho PP
    An Microbiol (Rio J); 1982; 27():51-67. PubMed ID: 6765359
    [No Abstract]   [Full Text] [Related]  

  • 2. [Influence of the inoculation route on residual virulence of different substrains of BCG for albino mice].
    Palhano Junior L; Gontijo Filho PP
    Rev Inst Med Trop Sao Paulo; 1980; 22(1):15-9. PubMed ID: 7001603
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative immunogenicity of BCG substrains for mice.
    Júnior LP; Gontijo Filho PP
    Rev Bras Pesqui Med Biol; 1979 Sep; 12(4-5):311-6. PubMed ID: 394227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Residual virulence of lyophilized commercial BCG-Brazil vaccine, and of the one cultured in Dubos media for mice].
    Fonseca Lde S; Gontijo Filho PP
    An Microbiol (Rio J); 1979; 24():182-9. PubMed ID: 400665
    [No Abstract]   [Full Text] [Related]  

  • 5. [Influence of culture conditions (oxygenation) on growth and morphology of BCG-Brazil and BCG-Glaxo vaccines].
    Feitosa JG; Gontijo Filho PP
    An Microbiol (Rio J); 1982; 27():69-79. PubMed ID: 6765360
    [No Abstract]   [Full Text] [Related]  

  • 6. Experimental study of the immunogenic and allergenic activity of different batches of Czechoslovak and Danish BCG vaccine in guinea pigs.
    Průchová J; Svandová E; Skrivanová R
    J Hyg Epidemiol Microbiol Immunol; 1970; 14(4):469-80. PubMed ID: 4924334
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of Bacillus Calmette-Guérin on immunosuppression from cyclophosphamide, methotrexate, and 5-fluorouracil.
    Sparks FC; Albert NE; Andreone PA; Breeding JH
    Cancer Res; 1977 Aug; 37(8 Pt 1):2560-4. PubMed ID: 326388
    [No Abstract]   [Full Text] [Related]  

  • 8. Indirect migration inhibition test in xenogeneic systems. I. Delayed hypersensitivity to BCG.
    Skopińska E; Zaleska-Rutczyńska Z; Wasik M; Komender A; Ostrowski K
    Bull Acad Pol Sci Biol; 1969; 17(10):589-93. PubMed ID: 4909017
    [No Abstract]   [Full Text] [Related]  

  • 9. Pathogenesis of pulmonary Mycobacterium bovis infection: basic principles established by the rabbit model.
    Dannenberg AM
    Tuberculosis (Edinb); 2001; 81(1-2):87-96. PubMed ID: 11463228
    [No Abstract]   [Full Text] [Related]  

  • 10. The efficacy of live tuberculosis vaccines after presensitization with Mycobacterium avium.
    de Lisle GW; Wards BJ; Buddle BM; Collins DM
    Tuberculosis (Edinb); 2005; 85(1-2):73-9. PubMed ID: 15687030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Variability of the BCG Moreau substrain. I. Comparison of morphology and residual virulence of BCG substrains of various origins].
    Janaszek W
    Med Dosw Mikrobiol; 1983; 35(2):85-95. PubMed ID: 6369042
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparative studies of 5 BCG substranins. I. Residual virulence of the French, Soviet, Swedish, Japanese and Rumanian substrains.
    Gheorghiu M; Paraschiveso M; Petrovici-Venson E
    Arch Roum Pathol Exp Microbiol; 1969; 28(2):531-9. PubMed ID: 4923821
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparability of delayed hypersensitivity in various rodents. II. Jones-Mote type hypersensitivity in guinea-pigs immunized with sheep erythrocytes and its modification by cyclophosphamide or BCG pre-treatment.
    Nomoto K; Yoshida S; Himeno K
    Immunology; 1980 Sep; 41(1):83-90. PubMed ID: 7429556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of the Brazilian, Russian and French BCG substrains based on the "safety test"].
    Buraczewska M; Chodkowska S; Paklerska-Pobratyn H
    Gruzlica; 1969 Feb; 37(2):93-9. PubMed ID: 4891544
    [No Abstract]   [Full Text] [Related]  

  • 15. [Sensitivity of the protection test in guinea pigs vaccinated by BCG. I. Influence of age or slight viability margins of BCG cultures].
    Frappier A; Portelance V; Marois P; St-Pierre J
    Ann Inst Pasteur (Paris); 1967 Sep; 113(3):425-47. PubMed ID: 4860409
    [No Abstract]   [Full Text] [Related]  

  • 16. Nicotinic acid production of BCG substrains in relationship to their residual virulence and immunogenic efficacy.
    Zureck A
    J Hyg Epidemiol Microbiol Immunol; 1975; 19(4):436-43. PubMed ID: 812905
    [No Abstract]   [Full Text] [Related]  

  • 17. Cellular regulation of lung granuloma formation and delayed- type hypersensitivity induced with BCG cell walls. Further evidence of involvement of cellular immunity in lung granuloma formation.
    Yamamoto K; Kato K; Kakinuma M; Brehmer W
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Mar; 251(3):357-68. PubMed ID: 7043952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential productions of lipid virulence factors among BCG vaccine strains and implications on BCG safety.
    Chen JM; Islam ST; Ren H; Liu J
    Vaccine; 2007 Nov; 25(48):8114-22. PubMed ID: 17954004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perspectives for BCG standardization.
    Lévy FM; Mande R; Conge G; Fillastre C; Orssaud E
    Bibl Tuberc; 1968; 24():63-190. PubMed ID: 4984263
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparative studies of different strains of BCG vaccine in mice: T-cell dependent immune responses.
    Lagrange PH
    Dev Biol Stand; 1977 Apr 13-15; 38():223-9. PubMed ID: 415920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.